Notice of NICHD's Participation in PA-16-292 "Mobile Health: Technology and Outcomes in LMIC (R21)"

Notice Number: NOT-HD-17-012

Key Dates
Release Date: July 18, 2017

Related Announcements
PAR-16-292

Issued by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

The purpose of this Notice is to inform potential applicants that the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will participate, effective immediately, in PAR-16-292, “Mobile Health: Technology and Outcomes in LMIC (R21)".

 
The following sections have been updated to reflect the participation of NICHD in this FOA:

Part 1. Overview Information

Components of Participating Organizations
Fogarty International Center (FIC)
National Cancer Institute (NCI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Mental Health (NIMH)
Office of Behavioral and Social Sciences Research (OBSSR)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Catalog of Federal Domestic Assistance (CFDA) Number(s) 
93.242;93.393;93.395;93.399;93.173;93.989; 93.286; 93.865.

Part 2

Section I

The Eunice Kennedy Shriver National Institute of Child Health and Human Development is seeking innovative approaches to achieving its mission.  The following research topics list the Institute's priorities for mHealth research in LMICs:

  • Use of mHealth technology for networking support systems that integrate family-focused primary healthcare and preventive services (e.g., prenatal care, infant and childhood nutrition, developmental disorders, immunizations, reproductive health.
  • Use of mHealth interventions to increase correct and consistent contraceptive use to decrease unintended pregnancies leading to better health outcomes of both mothers and babies.
  • Use of mHealth technology to lower HIV transmission, including through appropriate contraceptive use.
  • Use of mHealth technology to document menstrual bleeding patterns including frequency, duration, amount of blood loss, and associated pain (dysmenorrhea) for use by health care providers.
  • Use of mHealth approaches to enhance diagnosis and treatment of chronic pelvic pain or vulvar pain.
  • Use of mHealth technology to facilitate treatment of infertility.
  • Use of mHealth technology to facilitate scheduling, evaluation, monitoring and interactive management of ovarian stimulation.
  • Use of mHealth technologies to enhance screening for children with developmental disorders and develop community based treatment paradigms
  • Use of mHealth interventions for the development of diagnostic tests in children (e.g., infectious diseases, nutrient biomarkers, intellectual or developmental disability)
  • Use of mHealth technology to enhance prevention and treatment of life threatening injury and critical illness in children and families
  • Use of technology to respond to the needs of children exposed to and affected by such traumatic events as man-made or natural disasters, or war
  • Use of mHealth technologies to enhance provider/patient communication in order to improve health and health care of critically ill or injured pediatric patients

Use of mHealth to support health and community participation for people with disabilities (PWD), especially in light of more limited resources and clinical support. This may include remote support of exercise and specific therapies, periodic feedback on key clinical measures, and interactive communication between therapists and PWD.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Danuta Krotoski, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-496-5576
Email: krotoskd@mail.nih.gov